Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 12-2000 | 09-2000 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 16,730 | 23,330 | 3,750 | 470 | 0 |
| TOTAL | $16,730 | $23,330 | $3,750 | $470 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 8,030 | 0 |
| TOTAL | $0 | $0 | $0 | $8,030 | $N/A |
| Total Assets | $16,730 | $23,330 | $3,750 | $8,500 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,820 | 9,810 | 7,140 | 12,640 | 0 |
| Accrued Expenses | 7,370 | 7,460 | 6,770 | 3,570 | N/A |
| Other current liabilities | 560 | 7,050 | 3,890 | 5,760 | N/A |
| TOTAL | $24,750 | $24,320 | $17,800 | $25,640 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,560 | 11,980 | 0 | 7,110 | 0 |
| TOTAL | $11,560 | $11,980 | $0 | $32,090 | $N/A |
| Total Liabilities | $36,310 | $36,300 | $17,800 | $57,730 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 80 | 80 | 40 | 0 | N/A |
| TOTAL | $79,020 | $78,300 | $51,010 | $0 | $N/A |
| Total Liabilities And Equity | $115,330 | $114,600 | $68,810 | $57,730 | $0 |